Carmot Therapeutics Secures $500,159 New Financing Round

  • Feed Type
  • Date
    7/18/2012
  • Company Name
    Carmot Therapeutics
  • Mailing Address
    409 Illinois Street San Francisco, CA 94158
  • Company Description
    Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen and Daniel A. Erlanson while they were working at Sunesis Pharmaceuticals. Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing the technology.
  • Website
    http://www.carmot.us
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,159
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.